German Machinery Stock News

Ceconomy (XTRA:CEC) is back in focus after its H1 2026 results, which highlighted 4% sales growth, higher adjusted EBIT, and a larger online share, alongside updates on restructuring and JD.com acquisition delays. See our latest analysis for Ceconomy. Despite a 32.39% 1 year total shareholder return and an 84.33% total shareholder return over three years, Ceconomy’s recent 90 day share price return of 4.64% down suggests momentum has cooled ahead of the upcoming Q2 2026 earnings call and the...

Bayerische Motoren Werke (XTRA:BMW) is back in focus after executives outlined progress on reducing research and production costs for its Neue Klasse electric vehicle platform, supported by strong iX3 order intake and added capacity in Hungary. See our latest analysis for Bayerische Motoren Werke. The latest update on Neue Klasse comes after a weaker first quarter, where sales of €21,170 million and net income of €1,622 million were below the prior year. A year-to-date share price return that...

Why Siemens (XTRA:SIE) is back in focus after its latest earnings Siemens (XTRA:SIE) is back on many watchlists after reporting higher orders and revenue, highlighting strong demand in its Smart Infrastructure segment and unveiling a new €6b multi year share buyback program. See our latest analysis for Siemens. Despite the latest earnings beat and new buyback announcement, Siemens’ share price fell 5.15% on the day to €259.6. However, its 30 day share price return of 9.35% and 1 year total...

First quarter earnings put Hugo Boss stock in focus Hugo Boss (XTRA:BOSS) moved onto investors’ radar after first quarter 2026 results showed sales of €905 million, compared with €999 million a year earlier, and net income of €17 million, compared with €35 million. See our latest analysis for Hugo Boss. The earnings release landed against a share price of €36.01, with the stock showing a 1-day share price return of 1.27% but a 1-year total shareholder return that declined 10.29%, so near term...

Investors in SCHOTT Pharma AG & Co. KGaA ( ETR:1SXP ) had a good week, as its shares rose 4.9% to close at €16.38...

Dermapharm Holding (XTRA:DMP) just reported first quarter 2026 results, with sales of €309.1 million, net income of €45.2 million and earnings per share of €0.84 from continuing operations. See our latest analysis for Dermapharm Holding. The strong Q1 release, including higher revenue, net income and reaffirmed guidance, has coincided with a clear upswing in momentum, with a 40.38% 90 day share price return and a 55.95% 1 year total shareholder return from Dermapharm Holding. If this earnings...

Shareholders of Dermapharm Holding SE ( ETR:DMP ) will be pleased this week, given that the stock price is up 12% to...

Wondering whether Mercedes-Benz Group stock is attractively priced or just looks cheap at first glance? This breakdown focuses squarely on what you are getting for the current share price. The stock last closed at €50.35, with a mixed return profile that includes a 0.4% gain over the past week, a decline of 7.5% over the past month and a 2.6% gain over the past year. Recent headlines around Mercedes-Benz Group have focused on ongoing execution in its core premium vehicles business and the...

Enapter AG ( FRA:H2O ) is possibly approaching a major achievement in its business, so we would like to shine some...

E.ON (XTRA:EOAN) opened Q1 2026 earnings season with Q4 2025 revenue of about €22.0b and basic EPS of €0.31, setting a clear marker for how its €17.87 share price sits against the latest figures. Over recent quarters, revenue has ranged from €16.3b to €25.5b while basic EPS has swung between €0.20, €0.17 and a small loss of €0.02, giving investors a broad view of how earnings power has shifted since early 2025. With trailing net profit margins at 2.2% versus 5.5% a year earlier and a sizeable...

Borussia Dortmund GmbH Kommanditgesellschaft auf Aktien (XTRA:BVB) has just posted its latest quarterly figures, with Q2 2026 revenue at €141.4 million and a basic EPS loss of €0.04, set against trailing 12 month revenue of €598.5 million and EPS of €0.16 that reflect the recent move back into profit. Over the past few reported quarters, revenue has moved between €126.7 million and €161.4 million while basic EPS has swung from a loss of €0.05 in Q4 2025 to a profit of €0.21 in Q1 2026. This...

H&R GmbH KGaA (XTRA:2HRA) just posted Q1 2026 results off a difficult base. Q4 2025 revenue was €289.2 million and basic EPS showed a loss of €0.77, compared with Q4 2024 revenue of €334.6 million and EPS of €0.11. Over recent quarters, revenue has moved from €345.8 million and EPS of €0.05 in Q1 2025, through €307.3 million and an EPS loss of €0.04 in Q2 2025, to €310.6 million and an EPS loss of €0.02 in Q3 2025. This sets up a story where topline stability contrasts with a much weaker...

freenet (XTRA:FNTN) sets the stage with steady top line and consistent EPS freenet (XTRA:FNTN) has just opened its Q1 2026 reporting season with a backdrop of stable recent numbers, with Q4 2025 revenue at €619.3 million and basic EPS of €0.56, supported by trailing twelve month revenue of €2.47 billion and EPS of €2.28 heading into the new year. Over the last few quarters, revenue has ranged from €610.5 million to €621.5 million while quarterly EPS has moved between €0.48 and €0.68, giving...

Allianz (XTRA:ALV) opened 2026 with Q1 revenue of €28.8b and net income of €3.7b, translating into basic EPS of €9.71 as the insurer extended a run of solid trailing earnings that show 12 month basic EPS at €31.12 on revenue of €115.5b and net income of €11.9b. Over the past year, revenue has moved from €110.4b to €115.5b while basic EPS has shifted from €25.20 to €31.12, giving you a clear picture of how the top line and per share earnings have tracked together. With net profit margins...

Bayer (XTRA:BAYN) announced a major alliance with bp to commercialize camelina as a renewable fuel feedstock. The company reported positive Phase III results for its investigational cardiac amyloidosis diagnostic imaging agent. Both updates relate to Bayer’s agriculture and radiology activities and have not been covered in recent Simply Wall St articles. Bayer operates across pharmaceuticals, consumer health and crop science, and these two announcements touch both its agricultural and...

Recent share performance and business profile Talanx (XTRA:TLX) has drawn interest after a mixed period for the stock, with the price down 10% over the past month but roughly flat over the past 3 months. The €26.9b insurer generates €45,424.0m in revenue and €2,650.0m in net income, with operations spanning retail, corporate and reinsurance lines across Germany and multiple international markets. See our latest analysis for Talanx. Looking beyond the recent setback, the stock has a 1-day...

Hapag-Lloyd (XTRA:HLAG) has signed a new letter of intent with Southern Energy Renewables focused on low carbon fuels for its shipping operations. The agreement is validated by XCF Global Inc., which is set to support development and certification of sustainable aviation fuel and green methanol solutions. This move comes as the shipping sector increases attention on decarbonization and long term fuel supply options. Hapag-Lloyd is one of the major global container shipping companies, and...

TUI (XTRA:TUI1) has reported Q2 2026 revenue of €3.7b with a loss of €281.8m, or EPS of €0.56, setting a cautious tone after a profitable finish to 2025. The company has seen quarterly revenue move from €3.7b and EPS of €0.60 in Q2 2025 to €9.4b and EPS of €1.66 in Q4 2025, before easing back to €4.9b and EPS of €0.09 in Q1 2026. Investors are now weighing a fresh quarterly loss against trailing twelve month EPS of €1.38 as they assess how sustainable recent margin gains really look. See our...

RENK Group (XTRA:R3NK) is back in focus after confirming 2026 revenue guidance above €1.5b alongside its first quarter results, which showed sales of €283.61 million and net income of €15.35 million. See our latest analysis for RENK Group. Despite confirming revenue guidance above €1.5b, RENK Group’s recent momentum has softened, with the share price at €45.11, the 30 day share price return down 13.35%, and the 1 year total shareholder return down 18.41%. If you are weighing RENK Group’s...

Siemens Energy AG ( ETR:ENR ) missed earnings with its latest second-quarter results, disappointing overly-optimistic...

Last week saw the newest quarterly earnings release from 1&1 AG ( ETR:1U1 ), an important milestone in the company's...

Grand City Properties S.A. ( ETR:GYC ) shareholders are probably feeling a little disappointed, since its shares fell...

Verbio (XTRA:VBK) has just posted Q3 2026 results with revenue of €452.7 million and EPS of €0.36, set against a trailing twelve month picture that still shows a loss of €75.1 million on revenue of €1.8 billion and EPS of €1.18 in the red. Over recent quarters, revenue has moved from €395.3 million in Q2 2025 to €452.7 million in Q3 2026, while quarterly EPS has shifted from a loss of €0.06 in Q2 2025 to a profit of €0.36 in the latest period. This puts the focus firmly on how durable this...

Siemens Healthineers (XTRA:SHL) received FDA clearance in the US for six new Artis interventional imaging systems featuring the Optiq AI imaging chain with deep-learning-based noise reduction. The company also secured renewed CDC HoSt-TT program certification for its Atellica IM Testosterone II assay, confirming its measurement accuracy in hormone testing. For readers tracking medical technology, Siemens Healthineers sits at the intersection of advanced imaging and diagnostic testing, two...